Keyword: Active Pharmaceutical Ingredients (APIs)

Plant Construction & Process Technology

Essential Ingredients

08.05.2014 - Understanding The Source - Classification of today's supply chain - regarding all organic chemicals involved in the manufacturing of an API - is a useful tool for demonstrating...

Strategy & Management

International Drugmakers Meet Challenges

08.05.2014 - In contrast to chemicals, the global pharmaceutical industry is little plagued by market cyclicality or general economic swings. But it faces equally daunting challenges, as the...

Plant Construction & Process Technology

GDUFA’s Impact on the API Industry – an Update

02.04.2014 - The Price of Doing Business - Following the 2012 implementation of the Generic Drug User Fee Act (GDUFA), an article in CHEManager Europe's July/August 2013 edition about GDUFA's...

News

AMRI acquires Cedarburg Pharmaceuticals

26.03.2014 - AMRI announced that it has signed a definitive agreement to acquire all outstanding shares of Cedarburg Pharmaceuticals for US$38.2 million in cash. The transaction, including US$2...

Plant Construction & Process Technology

Duloxetine: Refining its Chemical Synthesis with Biocatalysis

09.03.2014 - Competing With Generics - With product innovation falling and drugs going off patent, the generic pharmaceutical market is becoming more predominant. It is expected that generics...

Plant Construction & Process Technology

Pharma In Africa

05.03.2014 - Up And Up - Long known for its struggles with infectious diseases and poverty, the continent of Africa is experiencing widespread economic growth. An increasing middle class and...

News

ICIG is Looking to Expand its Two Major Platforms

04.03.2014 - Investing in Chemicals - International Chemical Investors Group - better known by the initials ICIG - has become a household name in the chemical industry recently. The privately...

Plant Construction & Process Technology

U.S. API Manufacturing and Sustainability

16.01.2014 - Moving Away - Many would argue that the future of pharmaceutical growth in the coming years will come from emerging markets; U.S. pharma sales have been sluggish recently with a...